

Author: Kim Bo-Gyoung Kim Jin-Wook Kim Soo-Min Go Ryeo-Eun Hwang Kyung-A Choi Kyung-Chul
Publisher: MDPI
E-ISSN: 1422-0067|19|1|189-189
ISSN: 1422-0067
Source: International Journal of Molecular Sciences, Vol.19, Iss.1, 2018-01, pp. : 189-189
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Cyprodinil (CYP) is a pyrimidine amine fungicide that has been extensively used in agricultural areas. 3,3′-Diindolylmethane (DIM) is a derivative of the dietary phytoestrogen, indole-3-carbinol (I3C), which is derived from cruciferous vegetables and considered to be a cancer-preventive phytonutrient agent. In this study, the effects of CYP and DIM were examined on the cell viability, invasion, and metastasis of human endometrial cancer cells, Ishikawa, via epithelial mesenchymal transition (EMT). CYP increased the level of cell viability of Ishikawa cells compared to DMSO as a control, as did E2. Ishikawa cells lost cell-to-cell contact and obtained a spindle-shaped or fibroblast-like morphology in response to the application of E2 or CYP by the cell morphology assay. In the cell migration and invasion assay, CYP enhanced the ability of migration and invasion of Ishikawa cells, as did E2. E2 and CYP increased the expressions of N-cadherin and Snail proteins, while decreasing the expression of E-cadherin protein as EMT-related markers. In addition, E2 and CYP increased the protein expressions of cathepsin D and MMP-9, metastasis-related markers. Conversely, CYP-induced EMT, cell migration, and invasion were reversed by fulvestrant (ICI 182,780) as an estrogen receptor (ER) antagonist, indicating that CYP exerts estrogenic activity by mediating these processes via an ER-dependent pathway. Similar to ICI 182,780, DIM significantly suppressed E2 and CYP-induced proliferation, EMT, migration, and invasion of Ishikawa cancer cells. Overall, the present study revealed that DIM has an antiestrogenic chemopreventive effect to withdraw the cancer-enhancing effect of E2 and CYP, while CYP has the capacity to enhance the metastatic potential of estrogen-responsive endometrial cancer.
Related content


By Zhao Aiqi Kong Fancong Liu Chun-Jie Yan Guoxin Gao Fei Guo Hao Guo An-Yuan Chen Zhichao Li Qiubai
International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-02 ,pp. :




By Huang Sung-Ying Chang Shu-Fang Liao Kuan-Fu Chiu Sheng-Chun
International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-07 ,pp. :


By Jiang Yumao Jiao Yue Liu Yang Zhang Meiyu Wang Zhiguo Li Yujuan Li Tao Zhao Xiaoliang Wang Danqiao
International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. :


By Shin Yoonho Kim Gi Dae Jeon Ju-eun Shin Jongheon Lee Sang Kook
Marine Drugs, Vol. 11, Iss. 7, 2013-07 ,pp. :